SABS SAB Biotherapeutics Inc
Company Analysis
Latest News
🔴 SAB Biotherapeutics is trading 5% down; no specific catalyst identified
SAB Biotherapeutics is trading at $2.83, down 5.03%; no confirmed company-specific announcement explains the October 12 decline. - The latest identified...
🟢 SAB Biotherapeutics is trading 7.61% up in pre-market with no confirmed catalyst
SAB Biotherapeutics is trading at $3.11, up 7.61%, in pre-market, with no fresh company-specific announcement identified to explain the gain. - The company...
🔴 SAB Biotherapeutics is trading 5% down in pre-market
SAB Biotherapeutics is trading at $2.74, with a -5.19% move in pre-market and no clear catalyst identified. - No fresh company-specific announcement...
🔴 SAB Biotherapeutics is trading 7.6% down in pre-market with no clear company-specific catalyst identified
SAB Biotherapeutics is trading at $2.66, down 7.64% versus the October 7 close, with no clear company-specific catalyst identified for the October 8 pre-market...
🟢 SAB Biotherapeutics is trading 9.2% up in after-hours trading — catalyst remains unclear
SAB Biotherapeutics is trading at $3.20, up 9.22%, as the cause of the October 6 after-hours rise remains unclear. - The latest company release, dated October...
🔴 SAB Biotherapeutics is trading 5% down today with biotech-sector weakness the likeliest context
SAB Biotherapeutics is trading at $2.94, down 5.16%, with biotech-sector weakness the likeliest context; available evidence does not establish a direct...
🟢 SAB Biotherapeutics is trading 5.7% up with no confirmed catalyst
SAB Biotherapeutics is trading 5.7% higher at $3.15, with no confirmed company-specific catalyst identified for October 5, 2026. - The latest company...
🟢 SAB Biotherapeutics is trading 9.4% up in pre-market with no confirmed fresh catalyst
SAB Biotherapeutics is trading 9.4% up in pre-market at $3.26 on October 5, 2026, versus its October 2 close of $2.98; no fresh catalyst has been confirmed. -...